Sinopharm Group Co Ltd (1099)

Frankfurt


Symbol		Exchange		Currency
1099	·	Hong Kong	·	HKD	Delayed
SHTDY	·	OTC Markets	·	USD	Delayed
1099	·	Frankfurt	·	EUR	Delayed

Currency in EUR

2.0580

+0.0470(+2.34%)

Closed·20/06

Fair Value

Unlock Value

Day's Range

2.0120

2.0580

52 wk Range

1.8430

2.7170

1099 Income Statement

Explore the detailed Sinopharm Group Co Ltd income statement, offering a comprehensive view of the company’s financial performance. Review essential metrics such as revenue, gross profit, operating income, and net income over selected periods. This page provides a clear breakdown of profitability and operational efficiency, helping you evaluate Sinopharm Group Co Ltd's growth trends and overall financial health.

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Total Revenues

aa.aa

456,414.61

521,051.24

552,147.55

596,569.57

584,507.93

Total Revenues Growth

aa.aa

+7.32%

+14.16%

+5.97%

+8.05%

-2.02%

Cost Of Revenues

aa.aa

416,091.3

477,000.63

504,713.49

548,057.89

540,252.54

Gross Profit

aa.aa

40,323.31

44,050.61

47,434.06

48,511.68

44,255.39

Gross Profit Growth

aa.aa

+7.44%

+9.24%

+7.68%

+2.27%

-8.77%

Gross Profit Margin %

aa.aa

8.83%

8.45%

8.59%

8.13%

7.57%

Other Operating Expenses, Total

aa.aa

21,221.22

23,066.84

24,669.89

26,193.19

26,436.33

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+9.64%	+8.7%	+6.95%	+6.17%	+0.93%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	21,873.22	23,656.04	25,346.05	26,775.2	26,904.95
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-652	-589.19	-676.16	-582.01	-468.62

Operating Income

aa.aa

19,102.09

20,983.76

22,764.17

22,318.49

17,819.06

Operating Income Growth

aa.aa

+5.1%

+9.85%

+8.48%

-1.96%

-20.16%

EBIT Margin %

aa.aa

4.19%

4.03%

4.12%

3.74%

3.05%

Net Interest Expenses

aa.aa

-2,704.15

-3,154.55

-2,953.46

-2,162.28

-2,102.99

Net Interest Expenses Growth

aa.aa

+7%

-16.66%

+6.37%

+26.79%

+2.74%

Interest Expense, Total

aa.aa

-3,412.92

-3,745.1

-3,509.28

-2,945.69

-2,724.36

Interest And Investment Income

aa.aa

708.77

590.55

555.82

783.41

621.38

Other Non Operating Expenses, Total

aa.aa

563.25

719.89

600.36

805.57

852.34

EBT, Excl. Unusual Items

aa.aa

16,961.19

18,549.11

20,411.08

20,961.78

16,568.42

Gain (Loss) On Sale Of Assets

aa.aa

152.96

65.87

3.11

492.31

79.91

Other Unusual Items, Total

aa.aa

-40.07

-122.09

71.04

-66.68

EBT, Incl. Unusual Items

aa.aa

15,598.1

17,003.16

18,563.82

19,512.14

14,000.9

EBT, Incl. Unusual Items Growth

aa.aa

+13.36%

+9.01%

+9.18%

+5.11%

-28.25%

EBT, Incl. Unusual Items Margin

aa.aa

3.42%

3.26%

3.36%

3.27%

2.4%

Income Tax Expense

aa.aa

3,500.81

3,938.39

4,218.38

4,502.31

3,577.31

Net Income to Company

aa.aa

12,097.29

13,064.77

14,345.44

15,009.83

10,423.59

Minority Interest

aa.aa

-4,910.01

-5,306.13

-5,819.79

-5,956.07

-3,373.91

Net Income

aa.aa

7,187.28

7,758.65

8,525.66

9,053.76

7,049.68

Net Income Growth

aa.aa

+14.95%

+7.95%

+9.89%

+6.19%

-22.14%

Net Income Margin %

aa.aa

1.57%

1.49%

1.54%

1.52%

1.21%

Preferred Dividend and Other Adjustments

aa.aa

0.07

Net Income to Common Excl. Extra Items

aa.aa

7,187.2

7,758.65

8,525.66

9,053.76

7,049.68

Basic EPS - Continuing Operations

aa.aa

2.31

2.49

2.74

2.9

2.26

Basic EPS - Continuing Operations Growth

aa.aa

+9.74%

+7.62%

+10.02%

+6.07%

-22.14%

Diluted EPS - Continuing Operations

aa.aa

2.31

2.49

2.74

2.9

2.26

Diluted EPS - Continuing Operations Growth

aa.aa

+10%

+7.63%

+10.02%

+6.02%

-22.1%

Basic Weighted Average Shares Outstanding

aa.aa

3,111.17

3,120.66

3,116.82

3,120.53

Diluted Weighted Average Shares Outstanding

aa.aa

3,111.29

3,120.66

3,116.82

3,120.53

Dividend Per Share

aa.aa

0.69

0.75

0.82

0.87

0.68

Dividend Per Share Growth

aa.aa

+15%

+8.7%

+9.33%

+6.1%

-21.84%

EBITDA

aa.aa

20,882.11

22,895.67

24,776.58

24,403.53

19,970.54

EBITDA Growth

aa.aa

+4.98%

+9.64%

+8.22%

-1.51%

-18.17%

EBITDA Margin %

aa.aa

4.58%

4.39%

4.49%

4.09%

3.42%

EBIT

aa.aa

19,102.09

20,983.76

22,764.17

22,318.49

17,819.06

* In Millions of CNY (except for per share items)

US 30

42,254.30

+82.6

+0.20%

US 500

5,973.80

-7.1

-0.12%

Dow Jones

42,206.82

+35.16

+0.08%

S&P 500

5,967.84

-13.03

-0.22%

Nasdaq

19,447.41

-98.86

-0.51%

S&P 500 VIX

20.62

-1.55

-6.99%

Dollar Index

98.28

-0.190

-0.19%

Market Movers

Name	Last	Chg. %	Vol.
NVDA	143.85	-1.12%	242.96M
TSLA	322.16	+0.03%	108.69M
AAPL	201.00	+2.25%	96.81M
CRCL	240.28	+20.39%	92.43M
AMZN	209.69	-1.33%	75.35M
MSFT	477.40	-0.59%	37.58M
META	682.35	-1.93%	22.54M

Trending Stocks

Name	Last	Chg. %	Vol.
CRCL	240.28	+20.39%	92.43M
TSLA	322.16	+0.03%	108.69M
NVDA	143.85	-1.12%	242.96M
COIN	308.38	+4.43%	31.47M
AMD	128.24	+1.14%	79.93M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaaaa	127.04	+53.26%	194.70
Aaaaaaaaa Aaaa A	34.53	+45.89%	50.38
A A Aaaaaaa	314.35	+44.74%	454.99
Aaa Aa	15.84	+35.30%	21.43
Aa Aaaa A Aaaaaaaa	78.45	+32.30%	103.79
Aaaaa A	23.42	+26.93%	29.73
Aaaaa Aa	149.55	+26.58%	189.30

Name	Last	Upside	Fair Value
Aa Aaaaa	127.04	+53.26%	194.70
Aaaaaaaaa Aaaa A	34.53	+45.89%	50.38
A A Aaaaaaa	314.35	+44.74%	454.99
Aaa Aa	15.84	+35.30%	21.43
Aa Aaaa A Aaaaaaaa	78.45	+32.30%	103.79
Aaaaa A	23.42	+26.93%	29.73
Aaaaa Aa	149.55	+26.58%	189.30

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Name	Last	Chg. %	Vol.
KR	71.97	+9.84%	36.15M
BLDR	114.82	+7.46%	7.85M
KMX	68.57	+6.59%	12.46M
MDLZ	68.31	+2.95%	13.00M
LEN	106.42	+2.91%	5.78M
PARA	12.35	+2.57%	15.70M
NCLH	18.86	+2.56%	14.74M

Name	Last	Chg. %	Vol.
ACN	285.37	-6.86%	11.70M
APP	324.70	-5.71%	8.73M
CTSH	75.47	-4.64%	11.69M
ALB	56.66	-4.61%	5.55M
ANET	86.25	-4.42%	18.55M
GOOGL	166.64	-3.85%	75.66M
GOOG	167.73	-3.59%	55.40M

Popular Searches

Please try another search

Sinopharm Group Co Ltd (1099)

1099 Income Statement

Trending Stocks